XenoPatch, a Halle, Germany-based medtech startup, raised a Seven-Figure Pre-Seed funding.
The round was led by bmp Ventures with the IBG funds, supported by SCE Freiraum Ventures, the Berlin Angel Fund, and a group of experienced industry angel investors.
The company intends to use the funds to accelerate medical device approval, expedite market entry, and advance further development plans.
Led by CEO Paul Thouet, XenoPatch is a medtech startup specializing in the development of therapy solutions that combine heat, cold, and vibration to enhance the efficiency of therapeutic treatments. Its multi-patented device enables professionals and patients to conduct therapy sessions flexibly and effectively. The app-controlled device is wirelessly portable via a battery.
FinSMEs
17/07/2024